Legislative Update — Week of April 17, 2023 Post author:PacConAdmin Post published:April 18, 2023 Post category:Drug Industry Daily Source: Drug Industry Daily You Might Also Like Gottlieb Urges Drug Sponsors to Expand Access to Treatment After Trials March 29, 2019 Fresenius Petitions FDA to Deny Second Indication for Keryx’s Chronic Kidney Disease Drug July 12, 2017 EMA’s PRAC Recommends Additional Zinbryta Restrictions October 27, 2017
Fresenius Petitions FDA to Deny Second Indication for Keryx’s Chronic Kidney Disease Drug July 12, 2017
